Onclive Team

Articles

Renowned Urologic Oncologist Selected to Lead Urology/Bladder Cancer Program at NYU Langone Health

May 28th 2019

Gary D. Steinberg, MD, a nationally recognized specialist in the surgical management of bladder cancer, has been named director of the Goldstein Urology Bladder Cancer Program at NYU Langone Health.

Gaining Ground in GI Cancers in Durham

May 23rd 2019

We traveled to Durham, North Caroline, for a State of the Science Summit™ on Gastrointestinal Malignancies, where faculty shared key updates from the 2019 Gastrointestinal Symposium.

David Jaffray, PhD, Named Chief Technology and Digital Officer of MD Anderson Cancer Center

May 22nd 2019

The University of Texas MD Anderson Cancer Center named David Jaffray, PhD, as its first-ever chief technology and digital officer.

Examining Key Breast Cancer Updates in Chicago

May 16th 2019

We traveled to Chicago, Illinois, for a State of the Science Summit™ on Breast Cancer, where faculty provided a comprehensive look into present and potentially future standards of care in early-stage and advanced breast cancer subtypes.

Bold Named Physician-in-Chief of UC Davis Comprehensive Cancer Center

May 15th 2019

Richard Bold, MD, chief of the Division of Surgical Oncology, has been named Physician-in-Chief of the UC Davis Comprehensive Cancer Center.

Primary Care Physicians' Frustrations Mirror Those of Oncologists

May 12th 2019

In 2018, primary care physicians faced many of the same challenges as oncologists, according to the 90th Annual Physician Report from Medical Economics.

Getting Up to Speed On Key Developments in GI Cancers in Washington DC

May 9th 2019

We traveled to Washington, D.C., for a State of the Science Summit™ on Gastrointestinal Cancer, which focused on the clinically diverse and steadily expanding therapeutic armamentariums for patients with gastrointestinal malignancies.

Highlighting Pivotal Data From 2018 ASH Annual Meeting

May 2nd 2019

We traveled to Kansas City, Missouri, for a State of the Science Summit™ on Hematologic Malignancies, which provided a comprehensive snapshot of the pivotal data that were presented at the 2018 ASH Annual Meeting.

Experts Stress the Importance of Surveillance and Follow-Up in Lung Cancer Screening Programs

May 2nd 2019

The new online lung cancer screening (LCS) guide from the American Lung Association and the American Thoracic Society sets a clear pathway for physicians to surveil patients and provide follow-up from many institutions across the United States.

RCCA Oncology-Specialist Network Appoints Iuliana Shapira Chief Medical Officer

May 1st 2019

Regional Cancer Care Associates LLC, one of the nation’s largest networks of oncology specialists, has appointed Iuliana Shapira, MD, its chief medical officer.

OncLive Announces Steering Committee for First-Ever OncLive Global Expo

April 29th 2019

OncLive has announced its steering committee for the first OncLive® Global Expo, which will take place Oct. 11-13, 2019, at the Orlando World Center Marriott in Orlando, Florida.

USC Norris Launches Diversity-Driven Study Among Clinical Trial Participants

April 29th 2019

USC Norris Comprehensive Cancer Center has launched a study to determine how financial assistance for costs associated with clinical trial participation might increase enrollment, particularly among low-income patients and racial and ethnic minorities.

OncLive to Induct the 2019 Class of Giants of Cancer Care

April 25th 2019

OncLive® is proud to announce the inductees of the 2019 Giants of Cancer Care® recognition program.

Talking Tumors: MSK Faculty Highlight Ovarian Cancer Cases

April 25th 2019

Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, discuss two common clinical scenarios faced in practice, and the data to support their approaches.

$15.1M Awarded to Rutgers Cancer Institute of New Jersey for Redesignation as the State's Only Comprehensive Cancer Center

April 23rd 2019

Rutgers Cancer Institute of New Jersey, the state’s only Comprehensive Cancer Center as recognized by the National Cancer Institute, has been awarded a $15.1 million grant as part of its successful 2019 redesignation.

Wistar Earns 'Exceptional' Rating for NCI Cancer Center Support Grant for the Second Review Cycle in a Row, Demonstrating Strength of Science

April 23rd 2019

Wistar’s Cancer Center became the first National Cancer Institute-designated basic cancer center in the nation in 1972 and has held this national recognition for the past 46 years.

Folate Receptor Alpha as a Therapeutic Target for Ovarian Cancer

April 19th 2019

Investigational data are associated with folate receptor alpha-targeting agents, with an emphasis on the recent development and therapeutic potential of antibody-drug conjugates for the treatment of patients with ovarian cancer.

Getting Educated On Advances Made With GI Cancers in Houston

April 19th 2019

We traveled to Houston, Texas, for a State of the Science Summit™ on Gastrointestinal Cancer, which focused on the rapidly evolving landscapes of colorectal cancer, gastric/GEJ cancer, pancreatic cancer, neuroendocrine tumors, and hepatocellular carcinoma.

Hematology Researchers Join Sidney Kimmel Cancer Center at Jefferson

April 18th 2019

The Sidney Kimmel Cancer Center – Jefferson Health recently welcomed Anjali Mishra, PhD, and Nitin Chakravarti, PhD, to a growing team of researchers focused on hematologic cancers.

Moore Assesses Potential Impact of Antibody-Drug Conjugates in Ovarian Cancer Treatment

April 18th 2019

Kathleen N. Moore, MD, discusses the potential impact of antibody-drug conjugates on outcomes for patients with ovarian cancer.